医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Dr. Ravi Karra Joins Advanced Clinical to Accelerate Global Growth and Deliver Innovative Oncology Trials

2022年12月01日 AM12:00
このエントリーをはてなブックマークに追加


 

CHICAGO

Advanced Clinical, a clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey, is pleased to announce that Dr. Ravi Karra has been appointed Vice President, Oncology.

As a subject matter expert in brain tumors, melanoma and head and neck cancer with over 20 years of international experience in senior medical roles in academia and including pharma and CROs, Dr. Karra was instrumental in providing strategy for designing and conduct of clinical trials in several tumor types including rare cancers like glioblastoma, salivary gland, thyroid and uveal melanoma. He has been actively involved in innovative trial designs that utilize translational research data including molecular and imaging biomarkers. Dr. Karra has extensive experience working with regulatory bodies such as the FDA and EMA and has contributed to the success of many drug launches.

Dr. Karra will be key to Advanced Clinical’s continued expansion and strengthening of its current operations in the EMEA and APAC regions, which include offices in the UK, Ireland, and Germany.

“Having worked in multiple tumor types with immunotherapies, targeted therapies, and imaging diagnostics across all stages of development and marketing, I look forward to leveraging my expertise as a clinical developer in oncology for the benefit of patients and our customers across the globe,” said Dr. Karra.

“As we continue to expand internationally, we are excited to have Dr. Karra join our team as we seek to deliver more innovative oncology trials and elevate our strategy as leaders in oncology trial development,” said Julie Ross, President and CEO of Advanced Clinical. “Dr. Karra will be instrumental in accelerating business growth as we elevate our presence across all regions as a global leader in clinical research, FSP and strategic resourcing services with the goal of diversifying our global clinical programs for the clients and patients we serve.”

About Advanced Clinical

Advanced Clinical is a clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey. Our goal is to improve the lives of all those touched by clinical research – approaching each opportunity with foresight, character, resilience and innovation. Based on decades of experience, we help our clients achieve better outcomes by conducting candid conversations and anticipating potential issues through our customized solutions. Visit our website to learn more: www.advancedclinical.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221130005004/en/

CONTACT

Zoe Fenwick

Senior Marketing Manager, EMEA/APAC

P: +44 (0) 1483 917 276

zfenwick@advancedclinical.com

同じカテゴリーの記事 

  • InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
  • METIS第3相臨床試験で主要評価項目を達成、非小細胞肺がんからの脳転移患者における頭蓋内進行までの期間を統計学的に有意に延長
  • Poxel to Report Its 2023 Annual Results by the End of April 2024
  • Kolmar Korea Wins Case Against Italian Cosmetics Maker Intercos for Suncare Technology Theft
  • 大手CDMOのPCIファーマ・サービシズが初の包括ESG報告書を発表